Department of Epidemiology and Biostatistics, Faculty of Public Health, Khon Kaen University, Khon Kaen, Thailand.
ASEAN Cancer Epidemiology and Prevention Research Group, Khon Kaen University, Khon Kaen, Thailand.
PLoS One. 2021 Feb 16;16(2):e0246490. doi: 10.1371/journal.pone.0246490. eCollection 2021.
Cholangiocarcinoma (CCA) is a leading cause of cancer death in northeastern Thailand. We reported on the incidence of CCA using only one method. In the current study, we used three different statistical methods to forecast future trends and estimate relative survival.
We reviewed the CCA cases diagnosed between 1989 and 2018 recorded in the population-based Khon Kaen Cancer Registry (KKCR). Annual percent change (APC) was calculated to quantify the incidence rate trends using Joinpoint regression. Age-period-cohort models (APC model) were used to examine the temporal trends of CCA by age, calendar year, and birth cohort. We projected the incidence of CCA up to 2028 using three independent approaches: the Joinpoint, Age-period-cohort, and Nordpred models. Survival assessments were based on relative survival (RS).
The respective APC in males and females decreased significantly (-3.1%; 95%CI: -4.0 to -2.1 and -2.4%; 95%CI: -3.6 to -1.2). The APC model-AC-P for male CCA-decreased according to a birth-cohort. The CCA incidence for males born in 1998 was 0.09 times higher than for those born in 1966 (Incidence rate ratios, IRR = 0.09; 95%CI: 0.07 to 0.12). The relative incidence for female CCA similarly decreased according to a birth-cohort (IRR = 0.11; 95%CI: 0.07 to 0.17). The respective projection for the age-standardized rate for males and females for 2028 will be 7.6 per 100,000 (102 patients) and 3.6 per 100,000 (140 patients). The five-year RS for CCA was 10.9% (95%CI: 10.3 to 11.6).
The incidence rate of CCA has decreased. The projection for 2028 is that the incidence will continue to decline. Nevertheless, the survival of patients with CCA remains poor.
胆管癌(CCA)是泰国东北部癌症死亡的主要原因。我们仅使用一种方法报告了 CCA 的发病率。在当前的研究中,我们使用了三种不同的统计方法来预测未来趋势并估计相对生存率。
我们回顾了 1989 年至 2018 年期间在基于人群的孔敬癌症登记处(KKCR)中诊断出的 CCA 病例。使用 Joinpoint 回归计算年度百分比变化(APC),以量化发病率趋势。年龄-时期-队列模型(APC 模型)用于通过年龄、日历年份和出生队列检查 CCA 的时间趋势。我们使用三种独立的方法(Joinpoint、Age-period-cohort 和 Nordpred 模型)预测到 2028 年的 CCA 发病率。生存评估基于相对生存率(RS)。
男性和女性的 APC 分别显著下降(-3.1%;95%CI:-4.0 至-2.1 和-2.4%;95%CI:-3.6 至-1.2)。男性 CCA 的 APC 模型-AC-P 随出生队列而降低。1998 年出生的男性 CCA 发病率是 1966 年出生的男性的 0.09 倍(发病率比,IRR=0.09;95%CI:0.07 至 0.12)。女性 CCA 的相对发病率也随出生队列而降低(IRR=0.11;95%CI:0.07 至 0.17)。2028 年男性和女性年龄标准化发病率的预测值分别为 7.6/100,000(102 例患者)和 3.6/100,000(140 例患者)。CCA 的五年 RS 为 10.9%(95%CI:10.3 至 11.6)。
CCA 的发病率已下降。预计到 2028 年,发病率将继续下降。然而,CCA 患者的生存率仍然较差。